Context Therapeutics Inc. — Form 8-K
Filed July 31, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 92/100
What the filing says
On July 29, 2026, Context Therapeutics Inc. received notice of delisting or failure to satisfy continued listing standards. The filing does not specify the underlying reason, specific listing rule violated, or timeline for remediation. This is a critical corporate event for a ~$57.9M market-cap company.
Why this rating
Delisting is existential threat to public company viability, liquidity, and access to capital—regardless of company size. For a micro-cap, it is business-threatening.
Extracted items
See more from July 31, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.